Ulta Beauty (ULTA) reached $619.25 at the closing of the latest trading day, reflecting a -1.22% change compared to its last close.
Ulta Beauty is demonstrating a reacceleration in its core business, with revenue growth rebounding to 8.9% in Q2 2026 and operating margins stabilizing near 12.7%, suggesting successful navigation of a normalizing beauty cycle.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has reaccelerated to 8.9% in Q2 2026, with operating margins holding at 12.7%, indicating the company is effectively scaling its cost structure as top-line momentum returns.
The company is experiencing accelerating comparable sales momentum, indicating strong performance and growth.
Ulta Beauty is seeing enhanced consumer engagement, which drives repeat business and brand loyalty.
The company's conservative FY25 guidance leaves room for upside potential as performance exceeds expectations.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 27, 2026 | $6.55+5.3% vs $6.22 | $3.0B+1.6% vs $3.0B |
Q3 2026 Jun 2, 2026 | $7.74+12.3% vs $6.89 | $3.2B+1.4% vs $3.1B |
Q2 2026 Mar 12, 2026 | $8.01-1.1% vs $8.10 | $3.9B+1.6% vs $3.8B |
Q4 2025 Dec 4, 2025 | $5.14+11.5% vs $4.61 | $2.9B+5.3% vs $2.7B |
Ulta Beauty (ULTA) reached $619.25 at the closing of the latest trading day, reflecting a -1.22% change compared to its last close.
Ulta Beauty's bullish pattern breakout targets $690, but nearby support levels will test the recovery as traders assess the potential for further gains toward $883.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Here is how Ulta Beauty (ULTA) and Williams-Sonoma (WSM) have performed compared to their sector so far this year.
Benchmark ULTA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ulta Beauty, Inc. (ULTA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $644.76 | $27.72B | 23.19 | 9.71% | 9.34% | 45.4% | — | |
| $21.36 | $4.31B | 5.52 | -0.22% | 10.83% | — | 3.69% | |
| $116.14 | $6.84B | 80.55 | 24.59% | 4.47% | 7.39% | — | |
| $4.05 | $3.57B | -6.35 | -1.46% | -9.74% | -16.47% | 0.37% | |
| $18.31 | $1.75B | 9.32 | -0.42% | 5.16% | 23.11% | — | |
| $15.71 | $102.23M | -5.60 | -10.02% | -6.33% | -32.11% | — |
Ulta Beauty, Inc. (ULTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Ulta Beauty, Inc. (ULTA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 27, 2026·SEC
Aug 17, 2026·SEC
Jun 9, 2026·SEC
Get notified when ULTA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ulta Beauty, Inc. (ULTA) stock FAQ — growth, dividends, profitability & financials explained
Ulta Beauty, Inc. (ULTA) reported $12.96B in revenue over the trailing twelve months. Revenue was $12.39B in fiscal year 2025. That is 3321% more than the $362.2M of fiscal year 2002.
Ulta Beauty, Inc. (ULTA) grew revenue by 11.2% over the trailing twelve months, compared with the twelve months before.
Yes. Ulta Beauty, Inc. (ULTA) earned $1.21B in net income over the trailing twelve months (a 9.3% net margin).
Ulta Beauty, Inc. (ULTA) had a return on equity (ROE) of 45.4% over the trailing twelve months. That is well above the market's typical 10-15%.
Ulta Beauty, Inc. (ULTA) generated $1.07B in free cash flow over the trailing twelve months.